Brokerages expect Rite Aid Co. (NYSE:RAD) to post earnings per share of $0.03 for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Rite Aid’s earnings. The highest EPS estimate is $0.08 and the lowest is ($0.03). Rite Aid posted earnings per share of $0.20 during the same quarter last year, which indicates a negative year-over-year growth rate of 85%. The company is scheduled to report its next earnings report on Wednesday, December 18th.
On average, analysts expect that Rite Aid will report full-year earnings of ($0.06) per share for the current financial year, with EPS estimates ranging from ($0.23) to $0.12. For the next fiscal year, analysts anticipate that the business will report earnings of $0.09 per share, with EPS estimates ranging from ($0.23) to $0.41. Zacks Investment Research’s earnings per share calculations are an average based on a survey of research firms that that provide coverage for Rite Aid.
Rite Aid (NYSE:RAD) last issued its quarterly earnings data on Thursday, September 26th. The company reported $0.12 EPS for the quarter, topping analysts’ consensus estimates of $0.08 by $0.04. Rite Aid had a negative net margin of 2.12% and a positive return on equity of 0.02%. The business had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.41 billion. Rite Aid’s revenue was down 1.0% compared to the same quarter last year.
Several institutional investors have recently added to or reduced their stakes in the company. Invesco Ltd. lifted its holdings in shares of Rite Aid by 1.9% in the 2nd quarter. Invesco Ltd. now owns 2,626,062 shares of the company’s stock worth $21,035,000 after acquiring an additional 48,326 shares during the last quarter. Morgan Stanley lifted its holdings in Rite Aid by 81.7% during the 2nd quarter. Morgan Stanley now owns 1,978,559 shares of the company’s stock valued at $15,847,000 after buying an additional 889,900 shares in the last quarter. State Street Corp lifted its holdings in Rite Aid by 1.7% during the 3rd quarter. State Street Corp now owns 1,640,953 shares of the company’s stock valued at $11,405,000 after buying an additional 26,712 shares in the last quarter. Creative Planning lifted its holdings in Rite Aid by 523.7% during the 3rd quarter. Creative Planning now owns 638,816 shares of the company’s stock valued at $4,440,000 after buying an additional 536,390 shares in the last quarter. Finally, KLS Diversified Asset Management LP bought a new stake in Rite Aid during the 2nd quarter valued at about $4,114,000. Hedge funds and other institutional investors own 47.99% of the company’s stock.
Rite Aid stock opened at $9.06 on Thursday. The firm has a 50-day moving average price of $9.46 and a 200-day moving average price of $7.88. The company has a debt-to-equity ratio of 6.87, a quick ratio of 0.84 and a current ratio of 1.53. Rite Aid has a 12-month low of $5.04 and a 12-month high of $23.10.
Rite Aid Company Profile
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. It operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and a range of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products.
Recommended Story: What are popular green investing opportunities?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Rite Aid Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rite Aid and related companies with MarketBeat.com's FREE daily email newsletter.